Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
BMJ Open. 2022 May 12;12(5):e054185. doi: 10.1136/bmjopen-2021-054185.
Evaluate the association between symptoms and risk of non-ST segment elevation myocardial infarction (NSTEMI) in patients admitted to an emergency department with suspected acute coronary syndrome based on sex and age.
Post hoc analysis of a prospective observational study conducted between September 2015 and May 2019.
University hospital in Norway.
1506 participants >18 years of age (39.6% women and 31.0% 70 years of age or older).
The OR for NSTEMI was 9.4 if pain radiated to both arms, 3.0 if exertional chest pain was present during the last week and 2.9 if pain occurred during activity. Men had significantly lower OR compared with women if pain was dependent of position, respiration or palpation (OR 0.17 vs 0.53, p value for interaction 0.047). Patients <70 years had higher predictive value than older patients if they reported exertional chest pain the last week (OR 4.08 vs 1.81, 95%, p value for interaction 0.025) and lower if pain radiated to the left arm (OR 0.73 vs 1.67, p value for interaction 0.045).
Chest pain with radiation to both arms, exertional chest pain during the last week and pain during activity had the strongest predictive value for NSTEMI. The differences in symptom presentation and risk of NSTEMI between sex and age groups were small.
WESTCOR study ClinicalTrials.gov (NCT02620202).
根据性别和年龄,评估因疑似急性冠脉综合征而入住急诊科的患者的症状与非 ST 段抬高型心肌梗死(NSTEMI)风险之间的关联。
前瞻性观察性研究的事后分析,于 2015 年 9 月至 2019 年 5 月进行。
挪威大学医院。
1506 名年龄大于 18 岁的患者(39.6%为女性,31.0%年龄在 70 岁或以上)。
如果疼痛放射至双臂,NSTEMI 的比值比(OR)为 9.4;如果上周有劳累性胸痛,OR 为 3.0;如果活动时发生疼痛,OR 为 2.9。与女性相比,男性如果疼痛依赖于体位、呼吸或触诊,OR 显著降低(OR 0.17 比 0.53,交互作用 p 值为 0.047)。如果<70 岁的患者报告上周有劳累性胸痛(OR 4.08 比 1.81,95%置信区间,交互作用 p 值为 0.025),则其预测值更高,而如果疼痛放射至左臂,OR 则更低(OR 0.73 比 1.67,交互作用 p 值为 0.045)。
放射至双臂的胸痛、上周的劳累性胸痛和活动时的疼痛对 NSTEMI 具有最强的预测价值。性别和年龄组之间在症状表现和 NSTEMI 风险方面的差异较小。
WESTCOR 研究 ClinicalTrials.gov(NCT02620202)。